Multicenter Non-interventional Study on Efficacy, Tolerability, and Acceptance of Wellnara Containing 1.03 mg Estradiol Hemihydrate (Equivalent to 1 mg Estradiol) and 0.04 mg Levonorgestrel for Treatment of Hormone Deficiency Symptoms in Postmenopausal Women During 6 Cycles of 28 Days.
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2015
At a glance
- Drugs Estradiol/levonorgestrel (Primary)
- Indications Menopausal syndrome
- Focus Therapeutic Use
- Sponsors Bayer
- 22 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2010 Planned end date changed from 1 Jun 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 12 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.